Related Experiment Video
Updated: Jan 6, 2026

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
Engineered Stem Cells Provide Cancer-Killing iNKT Cells.
Mallory Paynich Murray1, Mitchell Kronenberg1
1La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
Engineering hematopoietic stem cells (HSCs) can create a continuous supply of invariant natural killer T (iNKT) cells. This approach aims to overcome the low frequency of iNKT cells for enhanced cancer immunotherapy. (Zhu et al., 2019).
Area of Science:
- Immunology
- Cancer Therapy
- Stem Cell Biology
Background:
- Invariant natural killer T (iNKT) cells show promise in cancer immunotherapy.
- The therapeutic application of iNKT cells is limited by their low natural frequency in patients.
Purpose of the Study:
- To develop a method for a sustained supply of iNKT cells.
- To overcome the frequency limitation of iNKT cells for improved cancer immune therapy.
Main Methods:
- Engineering hematopoietic stem cells (HSCs).
- Utilizing engineered HSCs to generate a continuous source of iNKT cells.
Main Results:
- Demonstrated a strategy to overcome iNKT cell scarcity.
- Proposed a novel approach for cancer immune therapy.
Conclusions:
- Engineered HSCs offer a potential solution for augmenting iNKT cell numbers.
- This strategy could enhance the efficacy of iNKT cell-based cancer therapies.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
iPS Cell Differentiation
Targeted Cancer Therapies
There are several types of targeted therapies against...
Induced Pluripotent Stem Cells
Somatic...
Induced Pluripotent Stem Cells

